24 Luglio 2026
Cina
CHINA OFFERS BRAND-NAME DRUGMAKERS A LIFELINE IN BULK-PROCUREMENT TENDER
China will allow more originator drugs to re-enter its national bulk-procurement program after missing the initial bidding round, expanding a mechanism intended to limit cutthroat price competition and preserve access to brand-name medicines in hospitals. (ICE PECHINO)
Fonte notizia: CX Daily
